Hoth Therapeutics' Price Target Increased by 11.11% to $5.10 Share

Hoth Therapeutics' (HOTH) average one-year price target has been revised to $5.10/share, an increase of 11.11% from $4.59/share. The price target is based on the average of many targets provided by analysts, ranging from $5.05 to $5.25/share. The average target represents a 508.16% increase from the latest reported closing price of $0.84/share. There are 26 funds reporting positions in HOTH, with 7 new owners and an increase in total shares owned by institutions.